Yujia Li
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Epidemiology top 10%
- Immunology top 10%
- Topics
- interferon and immune responses (13 papers)Liver Disease Diagnosis and Treatment (10 papers)SARS-CoV-2 and COVID-19 Research (9 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yujia Li
89 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 854
- Cancer Research 399
- Pulmonary and Respiratory Medicine 362
- Epidemiology 352
- Immunology 337
Countries citing papers authored by Yujia Li
This map shows the geographic impact of Yujia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Li more than expected).
Fields of papers citing papers by Yujia Li
This network shows the impact of papers produced by Yujia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Li. The network helps show where Yujia Li may publish in the future.
Co-authorship network of co-authors of Yujia Li
This figure shows the co-authorship network connecting the top 25 collaborators of Yujia Li. A scholar is included among the top collaborators of Yujia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujia Li. Yujia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 13 | |
| 13 | 42 | |
| 14 | 16 | |
| 15 | 2 | |
| 16 | 9 | |
| 17 | 3 | |
| 18 | 6 | |
| 19 | 4 | |
| 20 | 0 |
About Yujia Li
Yujia Li is a scholar working on Hepatology, Immunology and Infectious Diseases, having authored 95 papers that have together received 1.8k indexed citations. Recurring topics across this work include interferon and immune responses (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). The work is most often cited by research in Cancer Research (399 citations), Hepatology (155 citations) and Geriatrics and Gerontology (63 citations). Yujia Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jiangjuan Shao, Zili Zhang, Shizhong Zheng, Shanzhong Tan, Mei Guo, Anping Chen, Min Shen, Desong Kong, Shilin Li and Feng Zhang. Their work appears in journals such as Circulation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.